HRP980077A2 - Phenyl xanthine esters and amides - Google Patents

Phenyl xanthine esters and amides

Info

Publication number
HRP980077A2
HRP980077A2 HR9703044.9A HRP980077A HRP980077A2 HR P980077 A2 HRP980077 A2 HR P980077A2 HR P980077 A HRP980077 A HR P980077A HR P980077 A2 HRP980077 A2 HR P980077A2
Authority
HR
Croatia
Prior art keywords
bis
cyclohexylmethyl
compound
tetrahydro
purin
Prior art date
Application number
HR9703044.9A
Other languages
English (en)
Croatian (hr)
Inventor
Douglas Alan Livingston
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HRP980077A2 publication Critical patent/HRP980077A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR9703044.9A 1997-02-14 1998-02-13 Phenyl xanthine esters and amides HRP980077A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9703044.9A GB9703044D0 (en) 1997-02-14 1997-02-14 Phenyl xanthine esters and amides

Publications (1)

Publication Number Publication Date
HRP980077A2 true HRP980077A2 (en) 1998-12-31

Family

ID=10807635

Family Applications (1)

Application Number Title Priority Date Filing Date
HR9703044.9A HRP980077A2 (en) 1997-02-14 1998-02-13 Phenyl xanthine esters and amides

Country Status (37)

Country Link
US (3) US6355646B1 (is)
EP (1) EP0970081B1 (is)
JP (1) JP2001511792A (is)
KR (1) KR100522639B1 (is)
CN (1) CN1140527C (is)
AP (1) AP1000A (is)
AR (1) AR011441A1 (is)
AT (1) ATE304542T1 (is)
AU (1) AU754456B2 (is)
BG (1) BG103722A (is)
BR (1) BR9807682B1 (is)
CA (1) CA2280730C (is)
CO (1) CO4940444A1 (is)
CZ (1) CZ298764B6 (is)
DE (1) DE69831559T2 (is)
DK (1) DK0970081T3 (is)
EA (1) EA199900648A1 (is)
EE (1) EE9900348A (is)
ES (1) ES2249822T3 (is)
GB (1) GB9703044D0 (is)
HR (1) HRP980077A2 (is)
HU (1) HU225962B1 (is)
ID (1) ID22770A (is)
IL (1) IL131179A (is)
IS (1) IS5144A (is)
MY (1) MY118545A (is)
NO (1) NO325685B1 (is)
NZ (1) NZ336923A (is)
PE (1) PE58899A1 (is)
PL (1) PL188018B1 (is)
SK (1) SK110399A3 (is)
TR (1) TR199901942T2 (is)
TW (1) TW520371B (is)
UA (1) UA57767C2 (is)
WO (1) WO1998035966A1 (is)
YU (1) YU38399A (is)
ZA (1) ZA981175B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
US6545002B1 (en) * 1999-06-01 2003-04-08 University Of Virginia Patent Foundation Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
WO2002067942A2 (en) * 2001-02-28 2002-09-06 Smithkline Beecham Corporation Methods of treating irritable bowel syndrome and functional dyspepsia
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20080318983A1 (en) * 2001-11-09 2008-12-25 Rao Kalla A2b adenosine receptor antagonists
US20040072848A1 (en) * 2002-02-26 2004-04-15 Huber Brian E Methods of treating irritable bowel syndrome and functional dyspepsia
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
AU2012227249B2 (en) * 2003-12-16 2014-10-02 Nektar Therapeutics Chemically modified small molecules
CN1925875A (zh) * 2003-12-16 2007-03-07 尼克塔治疗亚拉巴马公司 化学改性的小分子
WO2005102976A1 (en) * 2004-04-21 2005-11-03 Smithkline Beecham Corporation Process for preparing nonaethylene glycol monomethyl ether
PL1789053T3 (pl) * 2004-09-01 2012-12-31 Gilead Sciences Inc Sposób gojenia się rany wykorzystujący antagonistów receptora adenozynowego A2B
US20070059740A1 (en) * 2005-08-26 2007-03-15 Linden Joel M Method of targeting a2b adenosine receptor antagonist therapy
US8193200B2 (en) * 2007-01-04 2012-06-05 University Of Virginia Patent Foundation Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8510758D0 (en) * 1985-04-27 1985-06-05 Wellcome Found Compounds
US4968672A (en) 1987-01-02 1990-11-06 The United States Of America As Represented By The Department Of Health And Human Services Adenosine receptor prodrugs
US5015647A (en) 1987-04-24 1991-05-14 Burroughs Wellcome Co. Method for treating viral infections
GB8826595D0 (en) 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
GB8906792D0 (en) 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
NZ240644A (en) 1990-11-21 1994-08-26 Smithkline Beecham Corp Use of xanthine derivatives to inhibit the production of tumour necrosis factor (tnf)
GB9210839D0 (en) * 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
TW252044B (is) * 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
GB9415529D0 (en) * 1994-08-01 1994-09-21 Wellcome Found Phenyl xanthine derivatives
DE19535504A1 (de) 1995-09-25 1997-03-27 Bayer Ag Substituierte Xanthine
SI0812844T1 (en) 1996-06-07 2003-02-28 Hoechst Aktiengesellschaft Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
US6117878A (en) 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
AU2640999A (en) 1998-02-26 1999-09-15 Zenyaku Kogyo Kabushiki Kaisha 1-azaindolizine derivatives
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
JP2003523958A (ja) 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−２の阻害剤、組成物ならびに使用法
US6751206B1 (en) * 2000-06-29 2004-06-15 Qualcomm Incorporated Method and apparatus for beam switching in a wireless communication system

Also Published As

Publication number Publication date
US6437124B1 (en) 2002-08-20
YU38399A (sh) 2002-06-19
BR9807682A (pt) 2000-02-15
TW520371B (en) 2003-02-11
AU6622198A (en) 1998-09-08
WO1998035966A1 (en) 1998-08-20
US20030181471A1 (en) 2003-09-25
AP9901622A0 (en) 1999-09-30
PL335135A1 (en) 2000-04-10
HU225962B1 (en) 2008-01-28
US6355646B1 (en) 2002-03-12
EA199900648A1 (ru) 2000-04-24
US7002012B2 (en) 2006-02-21
PE58899A1 (es) 1999-06-17
ES2249822T3 (es) 2006-04-01
EP0970081A1 (en) 2000-01-12
UA57767C2 (uk) 2003-07-15
KR100522639B1 (ko) 2005-10-19
NO325685B1 (no) 2008-07-07
CN1140527C (zh) 2004-03-03
TR199901942T2 (xx) 1999-12-21
AP1000A (en) 2001-08-11
ZA981175B (en) 1999-08-12
HUP0000894A3 (en) 2002-04-29
AU754456B2 (en) 2002-11-14
CA2280730A1 (en) 1998-08-20
KR20000071010A (ko) 2000-11-25
DE69831559T2 (de) 2006-06-14
CN1252071A (zh) 2000-05-03
IL131179A0 (en) 2001-01-28
CO4940444A1 (es) 2000-07-24
NO993915L (no) 1999-10-13
CA2280730C (en) 2006-10-10
EE9900348A (et) 2000-02-15
NZ336923A (en) 2001-02-23
NO993915D0 (no) 1999-08-13
MY118545A (en) 2004-12-31
ATE304542T1 (de) 2005-09-15
CZ288799A3 (cs) 2000-04-12
GB9703044D0 (en) 1997-04-02
ID22770A (id) 1999-12-09
HK1022907A1 (en) 2000-08-25
PL188018B1 (pl) 2004-11-30
CZ298764B6 (cs) 2008-01-23
BG103722A (en) 2000-06-30
DE69831559D1 (de) 2005-10-20
BR9807682B1 (pt) 2009-01-13
HUP0000894A2 (hu) 2001-05-28
AR011441A1 (es) 2000-08-16
IL131179A (en) 2004-05-12
DK0970081T3 (da) 2006-02-06
EP0970081B1 (en) 2005-09-14
JP2001511792A (ja) 2001-08-14
SK110399A3 (en) 2000-06-12
IS5144A (is) 1999-07-30

Similar Documents

Publication Publication Date Title
JP3631961B2 (ja) フェニルキサンチン誘導体
AP1000A (en) Substituted(1,3-Bis(cyclohexylmethyl)-1,2,3,6- tetrahydro-2, 6-dioxo-9h-purin-8-y1) phenyl derivatives, thier preparation and their use in the treatment of inflammatory conditions and immune disorders.
JPH10503767A (ja) フェニルキサンチン誘導体
MXPA99007508A (en) Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
HK1022907B (en) Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
HK1035195B (en) Phenyl xanthine derivatives
MXPA01001632A (en) Phenyl yanthine derivatives
CZ2001552A3 (cs) Fenylxanthinové deriváty

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20030109

Year of fee payment: 6

ODBI Application refused